4 completed, 2 withdrawn, 1 unknown. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 4, Withdrawn 2, Unknown 1 |
Follow iopromide: new trials by email Literature Review of iopromide trials Research Report on iopromide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pediatric Risk of Hypothyroidism With Iodinated Contrast Media Iohexol, Iodixanol, Iopromide - Hypothyroidism | Phase 4 | Withdrawn | GE Healthcare | 2022-03-01 | 2022-04-20 | |
| Renal Toxicity of Iodixanol and Iopromide in Patients With Renal Dysfunction iodixanol, iopromide - Kidney Failure, Chronic | Phase 4 | Unknown | Yong Huo | 200 | 2012-04-01 | 2013-10-16 |
| Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography iobitridol, iopromide, iomeprol - Coronary Artery Disease | Phase 4 | Completed | Guerbet | 468 | 2010-11-01 | 2015-12-16 |
| A Safety Comparison of Iopromide and Iodixanol in Renal Impaired Patients Iopromide (Ultravist), Iodixanol (Visipaque) - Kidney Failure, Chronic | Phase 4 | Completed | Chinese PLA General Hospital | 592 | 2009-02-01 | 2011-06-27 |
| Contrast-medium Induced Nephrotoxicity in Patients Undergoing Coronary Angiography - Iodixanol Versus Iopromide contrast agent (iopromide), contrast agent (iodixanol) - Chronic Renal Insufficiency, Coronary Angiography | Phase 4 | Completed | Seoul National University Bundang Hospital | 420 | 2009-02-01 | 2010-07-07 |
| Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI) Iodixanol, Iopromide - Contrast Induced Nephropathy, Acute Myocardial Infarction | Phase 4 | Completed | Ospedale San Donato | 432 | 2008-12-01 | 2010-11-16 |
| Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk Undergoing Coronary Angiography Iodixanol, Ioversol, Iopromide - Coronary Artery Disease (CAD), Renal Impairment | Phase 4 | Withdrawn | GE Healthcare | 2006-06-01 | 2019-04-29 |
Coronary Artery Disease (2) · Kidney Failure, Chronic (2) · Renal Insufficiency, Chronic (2) · Diabetes Mellitus (1) · Hypothyroidism (1) · Renal Insufficiency (1)
GE Healthcare (2) · Chinese PLA General Hospital (1) · Guerbet (1) · Ospedale San Donato (1) · Seoul National University Bundang Hospital (1) · Yong Huo (1)
China (2) · Germany (2) · Italy (2) · France (1) · South Korea (1) · Spain (1) · Switzerland (1) · United States (1)
Johnny Gibbs, Jr., CCRA (1) · Leonardo Bolognese, MD, FESC (1) · Marc Pignot, PhD (1) · Paul F. Sherwin, MD, PhD (1) · Philippe Bourrinet, PharmD (1) · Tae-Jin Youn, MD, PhD (1) · Yundai Chen, MD (1) · Zuzana Jirakova Trnkova, MD, PhD (1)